SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,592.00    6.00 (0.13%)
Bid:
4,590.00
Ask:
4,594.00
Spread: 4.00 (0.087%)
Market Cap: £16.74b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

9 Mar 2018 16:03

RNS Number : 3197H
Coca-Cola HBC AG
09 March 2018
 

FOR IMMEDIATE RELEASE

9 March 2018

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company has been notified of the following transaction by a person closely associated ('PCA') with a PDMR.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

SELENA TREUHAND AG

 

2

 

Reason for the notification

a)

 

Position/status

 

PCA OF CHRISTO LEVENTIS, DIRECTOR

b)

 

Initial notification /Amendment

 

AMENDMENT

c)

In case of amendment, please enter the previous notification reference number and explain the error that this notification is amending.

Reference is made to the Notification no. 00035075 submitted on 26/02/2018. Pursuant to a revised notification submitted by the PDMR Christo Leventis to the Company on 9/03/2018 (Revised Notification), the trust Selene Treuhand AG is the person closely associated ('PCA') with the PDMR Christo Leventis. Also, according to the Revised Notification, only 40,000 shares out of the shares sold by Selene Treuhand AG are indirectly attributable to the PDMR Christo Leventis.

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

 

SALE OF 20,830 SHARES BY SELENE TREUHAND AG, TRUSTEE OF A PRIVATE DISCRETIONARY TRUST FOR THE BENEFIT OF THE FAMILY OF THE LATE A.G. LEVENTIS (WHICH INCLUDES THE PDMR AND HIS FAMILY)

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

24.5092349

 

20,830

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

24.5092349

 

20,830

 

510,527.363

e)

 

Date of the transaction

 

2018-02-22

 

f)

 

Place of the transaction

 

XLON

5

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

 

SALE OF 19,170 SHARES BY SELENE TREUHAND AG, TRUSTEE OF A PRIVATE DISCRETIONARY TRUST FOR THE BENEFIT OF THE FAMILY OF THE LATE A.G. LEVENTIS (WHICH INCLUDES THE PDMR AND HIS FAMILY)

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

24.4230134

 

19,170

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

24.4230134

19,170

468,189.167

e)

 

Date of the transaction

 

2018-02-23

 

f)

 

Place of the transaction

 

XLON

 

This notification is made in accordance with the requirements of the EU Market Abuse Regulation.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 37

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKCDKABKDDNK
Date   Source Headline
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.